Weekly Briefing for November 8 to 14, 2026
From Physician in the Loop: Pathology · 3:01
Show by Nomad Medical
The Food and Drug Administration (FDA) issued final guidance on Nov. 9 on validating in vitro diagnostic tests for emerging pathogens during a Section 564 declared emergency, replacing a January 2025 draft.Waters announced 510(k) clearance of two BD OneFlow flow cytometry tests for B-cell lymphoma, and a National Kidney Foundation (NKF) workshop report said urinary albumin should generally be preferred over total protein.Read this week's roundup and its sources: https://physicianintheloop.org/specialties/pathology/2026-11-08/Get this roundup by email, freeThe voices on this episode are generated by AI, and so is the script, from the week's specialty roundup at Physician in the Loop. Every fact in the roundup links to its source.
More episodes of Physician in the Loop: Pathology
More episodes
- Weekly Briefing for November 1 to 7, 2026
- Weekly Briefing for October 25 to 31, 2026
- Weekly Briefing for October 11 to 17, 2026
- Weekly Briefing for September 28 to October 4, 2026
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.